Novartis (Azmarda) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Novartis (Azmarda) General Information
Description
A pharmaceutical brand catering to heart failure patients with reduced ejection fraction (HFrEF).
Contact Information
Corporate Office
- Switzerland
Corporate Office
- Switzerland
Novartis (Azmarda) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Novartis (Azmarda) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Novartis (Azmarda) FAQs
-
Where is Novartis (Azmarda) headquartered?
Novartis (Azmarda) is headquartered in Switzerland.
-
What industry is Novartis (Azmarda) in?
Novartis (Azmarda)’s primary industry is Buildings and Property.
-
Is Novartis (Azmarda) a private or public company?
Novartis (Azmarda) is a Private company.
-
What is the current valuation of Novartis (Azmarda)?
The current valuation of Novartis (Azmarda) is .
-
What is Novartis (Azmarda)’s current revenue?
The current revenue for Novartis (Azmarda) is .
-
Who are Novartis (Azmarda)’s investors?
Novartis has invested in Novartis (Azmarda).
-
When was Novartis (Azmarda) acquired?
Novartis (Azmarda) was acquired on 01-Apr-2022.
-
Who acquired Novartis (Azmarda)?
Novartis (Azmarda) was acquired by J. B. Chemicals & Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process